These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12434665)

  • 1. [Importance of clinical prognostic factors in the treatment of ovarian carcinoma].
    Spacek J; Petera J; Tesarík Z
    Ceska Gynekol; 2002 Sep; 67(5):280-5. PubMed ID: 12434665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Histopathologic prognostic factors, serum markers and selected molecular biologic factors in ovarian carcinoma].
    Spacek J; Jílek P; Petera J; Tesarík Z
    Ceska Gynekol; 2002 Nov; 67(6):343-9. PubMed ID: 12661373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic factors of mesenchymal and mixed tumors of uterus].
    Spacek J; Laco J; Petera J; Jílek P; Krepinská E; Rezác A; Stipl S
    Ceska Gynekol; 2009 Aug; 74(4):292-7. PubMed ID: 20564985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Para-aortic lymphadenectomy in gynecology. Theoretical principles, basic approach and practical suggestions].
    Spacek J; Veselský Z; Tosner J; Tesarík Z
    Ceska Gynekol; 2003 Mar; 68(2):99-105. PubMed ID: 12749178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in ovarian cancer.
    Friedlander ML
    Semin Oncol; 1998 Jun; 25(3):305-14. PubMed ID: 9633842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recurrent vulvovaginal candidiasis--possibility of its treatment].
    Spacek J; Buchta V; Jílek P; Krejsek J; Pidrman V; Kalousek I; Matula V; Kestránek J; Drahosová M; Vejsová M; Forstl M
    Ceska Gynekol; 2008 Jun; 73(3):179-84. PubMed ID: 18646671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic factors of ovarian cancer].
    Jancárková N; Krkavcová M; Janashia M; Freitag P
    Ceska Gynekol; 2006 May; 71(3):252-9. PubMed ID: 16768055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radiotherapy in the treatment of ovarian epithelial carcinoma].
    Petera J; Spacek J; Odrázka K
    Ceska Gynekol; 2003 Jul; 68(4):264-9. PubMed ID: 14515650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemoresistance/Chemosensitivity of ovarian cancer--a case report].
    Sedláková I; Tosner J; Rezác A; Cervinka M; Tomsová M; Spacek J
    Ceska Gynekol; 2008 Jun; 73(3):140-3. PubMed ID: 18646664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antifungal immunity and its mechanism in female genitalia].
    Spacek J; Jílek P; Buchta V; Drahosová M; Förstl M; Kalousek I
    Ceska Gynekol; 2004 Mar; 69(2):133-40. PubMed ID: 15141525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vulvodynia and the possibility of its management].
    Kestránek J; Matula V; Pidrman V; Taláb R; Jílek P; Buchta V; Spacek J
    Ceska Gynekol; 2010 Dec; 75(6):521-6. PubMed ID: 27534008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Systemic immunity in patients with recurrent vulvovaginal candidiasis].
    Jílek P; Spacek J; Buchta V; Kucera Z; Drahosová M; Förstl M; Andrýs C
    Ceska Gynekol; 2005 Nov; 70(6):453-9. PubMed ID: 17955799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in stage I ovarian carcinoma.
    Vergote I
    Verh K Acad Geneeskd Belg; 2001; 63(3):257-71; discussion 272-6. PubMed ID: 11499346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary drug resistance/sensitivity in vitro and clininical outcome in ovarian cancer patients].
    Sedláková I; Tosner J; Cervinka M; Brigulová K; Rezác A; Spacek J; Laco J; Skapinec P
    Ceska Gynekol; 2011 Jun; 76(3):184-9. PubMed ID: 21838147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Assessment of prognostic factors in common ovarian tumors of varying malignancy].
    Demeter A; Várkonyi T; Csapó Z; Szánthó A; Oláh J; Papp Z
    Magy Onkol; 2004; 48(3):259-65. PubMed ID: 15520877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Resistance/sensitivity in vitro in ovarian cancer patients].
    Sedláková I; Tosner J; Rezác A; Cervinka M; Brigulová K; Spacek J; Tomsová M; Skapinec P
    Ceska Gynekol; 2010 May; 75(3):182-7. PubMed ID: 20731297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vascular endothelial growth factor in ovarian cancer patients].
    Sedláková I; Tošner J; Kopecký O; Vroblová V; Rezáč A; Skapinec P; Andrýs C
    Ceska Gynekol; 2012 Oct; 77(5):415-20. PubMed ID: 23116346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A new opportunity in ovarian cancer treatment].
    Sedláková I
    Ceska Gynekol; 2012 Oct; 77(5):469-71. PubMed ID: 23116353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Microbiological findings in patients with recurrent vulvovaginal candidiasis in the Hradec Králové Faculty Hospital 1995-2002].
    Buchta V; Spacek J
    Ceska Gynekol; 2004 Jan; 69(1):7-14. PubMed ID: 15112380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular characterization of epithelial ovarian borderline tumors with respect to clinical management and prognosis].
    Zikán M; Pinkavová I; Sláma J; Freitag P; Janousek M; Fischerová D; Pavlista D; Cibula D
    Ceska Gynekol; 2009 Dec; 74(6):427-30. PubMed ID: 21246790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.